Trials / Completed
CompletedNCT07212452
Tranexamic Acid : Nebulization vs IV Route for Hemoptysis
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 172 (actual)
- Sponsor
- University of Health Sciences Lahore · Academic / Other
- Sex
- All
- Age
- 12 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study compares the effect of tranexamic acid on hemoptysis when given through the conventional IV route and Through nebulization.
Detailed description
The investigators are conducting a randomized controlled trial for the comparison of routes through which tranexamic acid can be given to control hemoptysis. The study participants will be divided into 2 groups randomly and 1 group will be assigned to use IV route while other will be assigned the nebulization route and the result variables include the time taken for complete control of hemoptysis and recurrence time. Another variable is the reduction in amout of blood in sputum after each intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic Acid (TXA) | In this study we are comparing the effect of tranexamic acid on hemoptysis when given through IV route and nebulization |
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2025-10-31
- Completion
- 2025-10-31
- First posted
- 2025-10-08
- Last updated
- 2025-11-28
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07212452. Inclusion in this directory is not an endorsement.